Imetelstat in myeloid malignancies: current data and future directions
Sign Up to like & getrecommendations! Published in 2025 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2025.2482721
Abstract: ABSTRACT Introduction Telomerase reactivation allows cancer cells to maintain telomere length and evade senescence, making it an appealing therapeutic target. Imetelstat, an antisense oligonucleotide, is the first clinically effective telomerase inhibitor approved by the FDA… read more here.
Keywords: current data; myeloid malignancies; data future; malignancies current ... See more keywords
Irreversible electroporation for the management of pancreatic cancer: Current data and future directions
Sign Up to like & getrecommendations! Published in 2023 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v29.i2.223
Abstract: Pancreatic cancer is currently the seventh leading cause of cancer death (4.5% of all cancer deaths) while 80%-90% of the patients suffer from unresectable disease at the time of diagnosis. Prognosis remains poor, with a… read more here.
Keywords: pancreatic cancer; data future; future directions; irreversible electroporation ... See more keywords